Issue 1/2015
Content (15 Articles)
Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma
Shelly M. Seward, Ira Winer
Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches
Hyun-Jin Choi, Guillermo N. Armaiz Pena, Sunila Pradeep, Min Soon Cho, Robert L. Coleman, Anil K. Sood
Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications
Ignace B. Vergote, Christian Marth, Robert L. Coleman
RETRACTED ARTICLE: Targeted immune therapy of ovarian cancer
Keith L. Knutson, Lavakumar Karyampudi, Purushottam Lamichhane, Claudia Preston
Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies
Cesar M. Castro, Hyungsoon Im, Christine Le, Hakho Lee, Ralph Weissleder, Michael J. Birrer
Proteomics of ovarian cancer: functional insights and clinical applications
Mohamed A. Elzek, Karin D. Rodland
The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal
Maarten F. Bijlsma, Hanneke W. M. van Laarhoven
Immunotherapy of melanoma: Present options and future promises
Anand Rotte, Madhuri Bhandaru, Youwen Zhou, Kevin J. McElwee
Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role?
R. E. Gardiner, S. Jahangeer, P. Forde, A. B. Ariffin, B. Bird, D. Soden, J. Hinchion
Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
Andrew McGuire, James A. L. Brown, Michael J. Kerin
HER2 expression status in diverse cancers: review of results from 37,992 patients
Min Yan, Maria Schwaederle, David Arguello, Sherri Z. Millis, Zoran Gatalica, Razelle Kurzrock
Erratum to: Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy
Stefano Fais, Giulietta Venturi, Robert A. Gatenby